¾«Æ·¹ú²úÒ»Çø¶þÇøÌÒÉ«

The ¾«Æ·¹ú²úÒ»Çø¶þÇøÌÒÉ« has announced the winners of the 2024 . All awardees are the first authors of standout JBC papers published the previous year.

The awards are named for the late Herb Tabor, who served as JBC’s editor-in-chief from 1971 to 2012 and upheld the journal’s mission to support the dissemination of science, enhance research visibility and promote scientific equity.

A committee of JBC associate editors selected the five award-winning first authors after carefully reviewing nominations from JBC readership, consulting experts in the field and evaluating the scientific quality and impact of nominated papers.

George DeMartino, a of physiology at the University of Texas Southwestern Medical Center and , oversees the award selections.

“The awardees were all first authors of high quality, rigorous, impactful science that is the hallmark of JBC,” DeMartino said. “These papers are already receiving citations in the literature, and the topics display the breadth of work that is covered by the journal.”

“These early-career scientists represent the next generation of authors, who will undoubtedly continue to contribute knowledge to the scientific community.”

Learn more about these outstanding early-career scientists and their research below.

Jenny Hogstrom

Jenny Hogstrim

is a postdoctoral research fellow, working with , an assistant professor of medicine at Harvard Medical School. In 2023, Hogstrom received the American Association for Cancer Research–AstraZeneca Breast Cancer Research Fellowship. Before moving to Boston, she completed her Ph.D. at the University of Helsinki. She was recognized for the paper “.” Hogstrom and her team developed a cell culture model of hormone receptor-positive, or HR+, breast cancer. They generated patient-derived organoids and matching cancer-associated fibroblasts from patient resections of primary and metastatic HR+ breast cancers. Finally, they showed that HR+ cancer-associated fibroblasts secrete cytokines that promote tumor growth and drive treatment resistance. 

Hannah Kondolf

Hannah Kondolf

Hannah Kondolf is pursuing her M.D. and recently earned her Ph.D. at Case Western Reserve University School of Medicine. She performed research with , a professor of medicine. Kondolf obtained her bachelor’s degree in human biology, health and society at Cornell University. She was recognized for the paper “.” This study shows that different gasdermin family members cause cell death via distinct mechanisms. Specifically, Kondolf and her team showed that gasdermin A preferentially targets mitochondria upon activation, unlike gasdermin D, which targets the mitochondria and plasma membrane equally.

Edwin Gabriel Peña Martínez

Edwin Gabriel Peña Martínez

is a graduate student of biochemistry. He works in the lab of , an associate professor of biology at the University of Puerto Rico, Río Piedras. Peña Martínez was recognized for the paper “.” Peña Martínez and his team used a machine learning model to identify and prioritize potential cardiovascular disease-causing single nucleotide polymorphisms, or SNPs. After identifying candidate non-coding SNPs using chromatin immunoprecipitation data of two cardiac transcription factors, NKX2-5 and TBX5, they found five variants that altered transcription factor binding and may cause cardiovascular disease.

Jianchao Zhang

Jianchao Zhang

is a research assistant professor at the Southern University of Science and Technology in China. He received his Ph.D. in cell biology from Northeast Normal University and completed postdoctoral training at the Shenzhen Institutes of Advanced Technology. He was recognized for the paper “.” Zhang and colleagues used single amino acid–based proteolysis-targeting chimera, or PROTAC, a system that targets harmful proteins for destruction by hijacking the ubiquitin-proteasome system, to degrade the proto-oncogene BCR–ABL. This fusion kinase drives the progression of chronic myeloid leukemia. This method successfully reduced tumor growth in mice with BCR–ABL positive tumors and could be adapted for broader applications in targeted protein degradation.
 

Gabriela Dias Noske

Gabriela Dias Noske

Gabriela Dias Noske is a cryogenic electron microscopy–associated researcher at the Brazilian Nanotechnology National Laboratory at the Center for Research in Energy and Materials. Recently, she completed her Ph.D. at the University of Sao Paulo, Brazil, under the guidance of USP professor Glaucius Oliva. Dias Noske completed her undergraduate degree at USP and has performed research on the structure and function of the yellow fever protease. She was recognized for the paper “.” In this study, she and colleagues characterized how clinically approved SARS-CoV-2 antivirals bind to their target, the viral protease, and how mutations in the protease affect their efficacy. Using X-ray crystallography, the team also showed that certain residues within the protease are critical for loss of antiviral potency.